Current status and future directions of clinical applications using iPS cells-focus on Japan

Regenerative medicine using iPS cell technologies has progressed remarkably in recent years. In this review, we summarize these technologies and their clinical application. First, we discuss progress in the establishment of iPS cells, including the HLA-homo iPS cell stock project in Japan and the advancement of low antigenic iPS cells using genome-editing technology. Then, we describe iPS cell-based therapies in or approaching clinical application, including those for ophthalmological, neurological, cardiac, hematological, cartilage, and metabolic diseases. Next, we introduce disease models generated from patient iPS cells and successfully used to identify therapeutic agents for intractable diseases. Clinical medicine using iPS cells has advanced safely and effectively by making full use of current scientific standards, but tests on cell safety need to be further developed and validated. The next decades will see the further spread of iPS cell technology-based regenerative medicine.

Keywords: cell therapy; clinical trial; disease modeling; iPS cell stock project; regenerative medicine.

© 2021 Federation of European Biochemical Societies.

Similar articles

Okano H, Yamanaka S. Okano H, et al. Mol Brain. 2014 Mar 31;7:22. doi: 10.1186/1756-6606-7-22. Mol Brain. 2014. PMID: 24685317 Free PMC article. Review.

Imaizumi Y, Okano H. Imaizumi Y, et al. J Neurochem. 2014 May;129(3):388-99. doi: 10.1111/jnc.12625. Epub 2013 Dec 15. J Neurochem. 2014. PMID: 24286589 Review.

Rami F, Beni SN, Kahnamooi MM, Rahimmanesh I, Salehi AR, Salehi R. Rami F, et al. Cell Reprogram. 2017 Apr;19(2):65-74. doi: 10.1089/cell.2016.0034. Epub 2017 Mar 7. Cell Reprogram. 2017. PMID: 28266864 Review.

Hanatani T, Takasu N. Hanatani T, et al. Rinsho Byori. 2017 Feb;65(2):160-166. Rinsho Byori. 2017. PMID: 30762982 Japanese.

Yamashita T, Takayama K, Hori M, Harada-Shiba M, Mizuguchi H. Yamashita T, et al. Biol Pharm Bull. 2019;42(3):312-318. doi: 10.1248/bpb.b18-00544. Biol Pharm Bull. 2019. PMID: 30828061 Review.

Cited by

Inagaki M. Inagaki M. J Dev Biol. 2023 Dec 20;12(1):1. doi: 10.3390/jdb12010001. J Dev Biol. 2023. PMID: 38535481 Free PMC article. Review.

Kitano M, Hayashi Y, Ohnishi H, Okuyama H, Yoshimatsu M, Mizuno K, Kuwata F, Tada T, Kishimoto Y, Morita S, Omori K. Kitano M, et al. Cell Transplant. 2024 Jan-Dec;33:9636897241228026. doi: 10.1177/09636897241228026. Cell Transplant. 2024. PMID: 38372247 Free PMC article.

Kuebler B, Alvarez-Palomo B, Aran B, Castaño J, Rodriguez L, Raya A, Querol Giner S, Veiga A. Kuebler B, et al. Stem Cell Res Ther. 2023 Dec 13;14(1):366. doi: 10.1186/s13287-023-03576-1. Stem Cell Res Ther. 2023. PMID: 38093328 Free PMC article.

Shoda H, Natsumoto B, Fujio K. Shoda H, et al. Inflamm Regen. 2023 Oct 24;43(1):51. doi: 10.1186/s41232-023-00303-4. Inflamm Regen. 2023. PMID: 37876023 Free PMC article. Review.

Zhang P, Zhang G, Wan X. Zhang P, et al. J Hematol Oncol. 2023 Aug 18;16(1):97. doi: 10.1186/s13045-023-01492-8. J Hematol Oncol. 2023. PMID: 37596653 Free PMC article. Review.

References

    1. Takahashi K & Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
    1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K & Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
    1. Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M et al. (2019) Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev 99, 79-114.
    1. Valamehr B, Robinson M, Abujarour R, Rezner B, Vranceanu F, Le T, Medcalf A, Lee TT, Fitch M, Robbins D et al. (2014) Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep 2, 366-381.
    1. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II & Thomson JA (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801.